October 16, 2008 – Echo Therapeutics (OTCBB: ECTE) announced the issuance of U.S. Patent 7,432,069 covering compositions and methods for the preparation of a polyethylene glycol (PEG)- based hydrogel as a key component of Echo’s Symphony™ Transdermal Continuous Glucose Monitoring (tCGM) System... [PDF] Echo Therapeutics' Press Release -
Friday, October 17, 2008
Echo Therapeutics : Issuance of New Patent for Symphony™ Transdermal Continuous Glucose Monitoring System
October 16, 2008 – Echo Therapeutics (OTCBB: ECTE) announced the issuance of U.S. Patent 7,432,069 covering compositions and methods for the preparation of a polyethylene glycol (PEG)- based hydrogel as a key component of Echo’s Symphony™ Transdermal Continuous Glucose Monitoring (tCGM) System... [PDF] Echo Therapeutics' Press Release -
